A hemodynamic study of pulmonary hypertension in sickle cell disease. - Wikidata - awgldk - TriplyDB

A hemodynamic study of pulmonary hypertension in sickle cell disease.

A hemodynamic study of pulmonary hypertension in sickle cell disease.

http://www.wikidata.org/entity/Q49084691

about

β-thalassemia intermedia: a clinical perspective Biomarkers and recent advances in the management and therapy of sickle cell disease 2015 Clinical trials update in sickle cell anemia Morphine for the treatment of pain in sickle cell disease Advances in sickle cell therapies in the hydroxyurea era Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia Risk Factors of Pulmonary Hypertension in Brazilian Patients with Sickle Cell Anemia Group 5 Pulmonary Hypertension: The Orphan's Orphan Disease.The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.Doppler echocardiography inaccurately estimates right ventricular pressure in children with elevated right heart pressure Pulmonary complications of sickle cell disease.Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy.Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe.Pulmonary hypertension in Nigerian adults with sickle cell anemia.Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease.Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease.Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Blood pressure levels and prognosis of intracranial trauma patients with cognitive dysfunction.Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Krüppel-like factor Association of coagulation activation with clinical complications in sickle cell disease Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review.Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia.Left ventricular dysfunction in patients with suspected pulmonary arterial hypertension.Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study.Mechanistic insights and characterization of sickle cell disease-associated cardiomyopathy Vasculopathy and pulmonary hypertension in sickle cell disease.Pulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the Literature Pulmonary Haemodynamics in Sickle Cell Disease Are Driven Predominantly by a High-Output State Rather Than Elevated Pulmonary Vascular Resistance: A Prospective 3-Dimensional Echocardiography/Doppler Study.Outcomes in elderly intensive care unit patients, pulmonary hypertension in sickle cell disease, and total liquid ventilation for therapeutic hypothermia after cardiac arrest in rabbits.Hemodynamic characteristics and predictors of pulmonary hypertension in patients with sickle cell disease The WHO classification of pulmonary hypertension: A case-based imaging compendium.QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.Relationship between Right Ventricular Longitudinal Strain, Invasive Hemodynamics, and Functional Assessment in Pulmonary Arterial Hypertension.Severe pulmonary hypertension: The role of metabolic and endocrine disorders.Doppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq.

P2860

Q26828512-5BAE1EB7-BDDE-4CF3-B75E-91EDB58CB9A8 Q28082462-8BC975A8-3BF7-4BEF-BE1F-0B3CEC342766 Q28086979-C0DBB061-2405-427A-9F85-0B515B34BB4E Q28087296-79168C53-AFC8-4CA2-A8A9-02CF9E79B65C Q28088552-34D0D983-0416-4029-BFCA-274CE2DE6D59 Q28395387-E4D59E73-7AC0-422E-A9B3-B582788EC443 Q28547742-9B6E13F9-EE72-485C-9E1E-B1403385EDC0 Q30248872-802F3447-591D-4D4B-9990-931EEE167028 Q30250302-4B07CE3E-61C9-4BBF-8F10-4D82BBE06C85 Q30419778-F6ECD75F-5669-414C-8332-709BE9A64C3A Q30515769-4D65C431-78C8-4BE5-8371-74746CF9D58E Q33418088-A1DC9B8B-3BA0-420A-896D-ED7D5EEE5617 Q33574142-43214D90-77B0-42D6-B129-C56B4AF9E567 Q33674097-3DA3628D-2CAE-4D2F-B330-8CB7F4C20D60 Q33690218-9BF98E38-4DED-46C9-9E6E-172EA4723092 Q33805998-31F486D7-7FAA-4BDF-8E57-85A00D845049 Q33806253-89877B79-EF86-4A7E-8998-058B03406402 Q33834751-38D6DAF8-6BD8-480F-9518-4785EEFE5A1B Q33837174-AED78002-33DE-4FC1-B890-F9AC27A5DD3E Q33956819-E7690D60-5307-4CAC-826D-F865CC4842E4 Q34001914-53AB75E4-7C0E-4DDE-91F1-C34674BD402D Q34019609-99EA5045-53DA-4CFB-93D2-5A675BC8802F Q34130633-0D4B821D-51AA-4A93-BFE4-3A27DFB51B05 Q34470834-CE5E5D1D-CCFF-4AA2-ADA2-6CF897C3F3FE Q34872759-D1113137-C6FC-47BF-91E6-A96E211F33E8 Q34959995-0DFA4DFD-8376-478C-9740-395D5F807FB9 Q34993093-99BC276D-0BB0-408D-8D01-CA0D45A0832B Q34994543-885A0F37-42AE-4FC5-BC76-21C9A1A338BB Q35041547-BE3DB785-2DD5-4705-9030-B1F42D143C06 Q35078958-A5110B05-CE18-4403-A1BF-61872A19EFD3 Q35086394-632C07B5-4933-4B8D-A24F-95B9E8FDAFEB Q35296597-CE234E5F-03D3-4F47-84B8-C3B4FAD5D91A Q35744966-121C6101-B5B7-4BCC-8CF5-70262809D870 Q35813664-37928E4F-FC12-4E20-AB14-594214FAC2D0 Q35892520-8A909245-D3AB-46F5-B52F-71C5E2CC8DE3 Q35929731-DD9F0C33-7863-465F-B6B2-5AFEF246090D Q36075721-B7C14856-965D-49FD-B2B8-939B074CEBE7 Q36087465-3D32A332-FB61-4996-BBBA-D48AA5D00408 Q36108039-66051A85-FAD9-44A0-8B61-1309EC223AF1 Q36119758-FAA947CA-2095-46F8-B082-82D9992743F1

P2860

A hemodynamic study of pulmonary hypertension in sickle cell disease.

http://www.wikidata.org/entity/Q49084691

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

A hemodynamic study of pulmonary hypertension in sickle cell disease.

@en

A hemodynamic study of pulmonary hypertension in sickle cell disease.

@nl

type

label

A hemodynamic study of pulmonary hypertension in sickle cell disease.

@en

A hemodynamic study of pulmonary hypertension in sickle cell disease.

@nl

prefLabel

A hemodynamic study of pulmonary hypertension in sickle cell disease.

@en

A hemodynamic study of pulmonary hypertension in sickle cell disease.

@nl

P1433

Q49084691-C0E606DF-85A4-4053-B81A-C255C7EC3D2E

P1476

Q49084691-34438115-7D78-40F8-BDB5-D986DD993BCC

P2093

Q49084691-11DD342D-2861-48EB-9FC3-83CF9B3AEF42

Q49084691-31B2820A-4EF9-4AF8-9025-64A2D42C2868

Q49084691-33133CB0-83AA-4712-AFCB-69BB677F38D3

Q49084691-3383834E-CBA4-4700-9749-81DAAC95517D

Q49084691-37AD883C-2298-4035-A645-65FFBEC2FFC7

Q49084691-3F8E7758-7106-4BF3-B389-DA43E9834E04

Q49084691-50595A5D-02E1-4DB3-A1DF-BA62B7D6B090

Q49084691-69AC71BE-A9BE-4C54-936F-5338787A3306

Q49084691-6CCFF77C-0AAC-4FB8-87C4-5B57DA08F9D0

Q49084691-798B1322-2490-4802-A5D5-48EF02CD9EFC

P304

Q49084691-BFD2677E-E72D-4627-94FD-774A4D9D3910

P31

Q49084691-60957709-5A6A-4C24-9E59-F690C628CB12

P356

Q49084691-766DA5A5-526D-4606-9DF0-BF917893393B

P407

Q49084691-345B374F-0850-49B3-B3B8-F67E5144132B

P433

Q49084691-4A1B3CD7-5D69-4A3C-B236-3120B277081B

P478

Q49084691-EFB9EF56-F688-4416-904D-4F684FE46734

P577

Q49084691-B862E7D8-7D7C-4538-9537-BD9178CBFA8C

P698

Q49084691-3A9E53E4-CDB6-4AF6-B872-983FD852F42A

P921

Q49084691-693A6AFD-AE11-486D-B72F-159756406EC6

Q49084691-D0875353-DFB3-4E64-89DF-48613BD2A532

P356

P1433

The New England Journal of Medicine

P1476

A hemodynamic study of pulmonary hypertension in sickle cell disease.

@en

P2093

Anoosha Habibi

http://www.w3.org/2001/XMLSchema#string

Azzedine Yaïci

http://www.w3.org/2001/XMLSchema#string

Bernard Maitre

http://www.w3.org/2001/XMLSchema#string

Dermot S O'Callaghan

http://www.w3.org/2001/XMLSchema#string

Dora Bachir

http://www.w3.org/2001/XMLSchema#string

Florence Parent

http://www.w3.org/2001/XMLSchema#string

François Lionnet

http://www.w3.org/2001/XMLSchema#string

Françoise Driss

http://www.w3.org/2001/XMLSchema#string

Frederic Galacteros

http://www.w3.org/2001/XMLSchema#string

Gerald Simonneau

http://www.w3.org/2001/XMLSchema#string

P304

44-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1005565

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

365

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21732836

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease